Search results
Subdued Growth No Barrier To Tango Therapeutics, Inc. (NASDAQ:TNGX) With Shares Advancing 25%
Simply Wall St. via Yahoo Finance· 5 months agoTango Therapeutics, Inc. (NASDAQ:TNGX) shares have had a really impressive month, gaining 25% after...
Marker Therapeutics Inc's Uncertain Future: Understanding the Barriers to Outperformance
GuruFocus.com via Yahoo Finance· 8 months agoLong-established in the Biotechnology industry, Marker Therapeutics Inc (NASDAQ:MRKR) has enjoyed a...
Subdued Growth No Barrier To Crescita Therapeutics Inc.'s (TSE:CTX) Price
Simply Wall St. via Yahoo Finance· 11 months agoWith a median price-to-sales (or "P/S") ratio of close to 1x in the Pharmaceuticals industry in...
Denali Therapeutics Q1 2024 Earnings: Misses Revenue Estimates Amid Strategic Shifts
GuruFocus.com via Yahoo Finance· 2 hours agoNet Loss: Reported a net loss of $101.8 million for Q1 2024, which is an improvement from a net loss of $109.8 million in Q1 2023, but above the estimated net loss of $105.7 million. Revenue ...
Nurix Therapeutics, Inc.'s (NASDAQ:NRIX) Price Is Right But Growth Is Lacking After Shares Rocket...
Simply Wall St. via Yahoo Finance· 5 months agoThose holding Nurix Therapeutics, Inc. (NASDAQ:NRIX) shares would be relieved that the share price...
Benign Growth For Carisma Therapeutics, Inc. (NASDAQ:CARM) Underpins Stock's 42% Plummet
Simply Wall St. via Yahoo Finance· 6 months agoUnfortunately for some shareholders, the Carisma Therapeutics, Inc. (NASDAQ:CARM) share price has...
Cidara Therapeutics, Inc. (NASDAQ:CDTX) Looks Inexpensive After Falling 39% But Perhaps Not...
Simply Wall St. via Yahoo Finance· 1 year agoCidara Therapeutics, Inc. (NASDAQ:CDTX) shareholders won't be pleased to see that the share price...
Investors Don't See Light At End Of Heron Therapeutics, Inc.'s (NASDAQ:HRTX) Tunnel
Simply Wall St. via Yahoo Finance· 1 year agoHeron Therapeutics, Inc.'s (NASDAQ:HRTX) price-to-sales (or "P/S") ratio of 2.6x might make it look...
Voyager Therapeutics Inc (VYGR) Reports Q3 2023 Financial Results
GuruFocus.com via Yahoo Finance· 6 months agoVoyager Therapeutics Inc (NASDAQ:VYGR) reported a net loss of $25.9 million in Q3 2023, compared to...
Voyager Therapeutics, Inc. (NASDAQ:VYGR) Q4 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 2 months agoVoyager Therapeutics, Inc. (NASDAQ:VYGR) Q4 2023 Earnings Call Transcript February 28, 2024 Voyager...